154 related articles for article (PubMed ID: 6311774)
1. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
Abbruzzese G; Gandolfo C; Loeb C
Ital J Neurol Sci; 1983 Jun; 4(2):169-72. PubMed ID: 6311774
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
[TBL] [Abstract][Full Text] [Related]
3. Intravenous methylprednisolone for multiple sclerosis in relapse.
Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
[TBL] [Abstract][Full Text] [Related]
4. [Steroid therapy for multiple sclerosis].
Oishi C; Sakuta M
Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
Cochrane Database Syst Rev; 2000; (4):CD001331. PubMed ID: 11034713
[TBL] [Abstract][Full Text] [Related]
6. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
[TBL] [Abstract][Full Text] [Related]
7. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
Tremlett HL; Luscombe DK; Wiles CM
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids and multiple sclerosis.
Miller DH
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):290. PubMed ID: 9728938
[No Abstract] [Full Text] [Related]
9. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
[TBL] [Abstract][Full Text] [Related]
10. Methylprednisolone in multiple sclerosis: a comparative dose study.
Bindoff L; Lyons PR; Newman PK; Saunders M
J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1108-9. PubMed ID: 3063777
[No Abstract] [Full Text] [Related]
11. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
Wender M; Tokarz-Kupczyk E; Mularek O
Neurol Neurochir Pol; 1989; 23(3):188-92. PubMed ID: 2561379
[TBL] [Abstract][Full Text] [Related]
12. [Corticoids and multiple sclerosis].
Defer G; Cesaro P; Degos JD
Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():37-41. PubMed ID: 8074340
[No Abstract] [Full Text] [Related]
13. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
Uttner I; Müller S; Zinser C; Maier M; Süssmuth S; Claus A; Ostermann B; Elitok E; Ecker D; Brettschneider J; Gold R; Tumani H
Neurology; 2005 Jun; 64(11):1971-3. PubMed ID: 15955958
[TBL] [Abstract][Full Text] [Related]
14. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
Wender M; Tokarz-Kupczyk E; Mularek O
Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
[TBL] [Abstract][Full Text] [Related]
15. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Frequin ST; Lamers KJ; Borm GF; Barkhof F; Jongen PJ; Hommes OR
Acta Neurol Scand; 1993 Aug; 88(2):80-6. PubMed ID: 8213063
[TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
Rinne UK
Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
[No Abstract] [Full Text] [Related]
17. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
Blustein H; Wasserman RR; Halperin L; Garvin JS
Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
[No Abstract] [Full Text] [Related]
20. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
Alam SM; Kyriakides T; Lawden M; Newman PK
J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
